Company Filing History:
Years Active: 2022-2024
Title: Innovations of Sunha Yoon in Immunotherapy
Introduction
Sunha Yoon is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of immunotherapy, particularly through his innovative patents. With a total of two patents to his name, Yoon's work focuses on developing therapeutic agents that target specific proteins involved in immune responses.
Latest Patents
Yoon's latest patents include a monoclonal antibody specifically binding to LAG-3 and an antibody against human DLK1. The first patent describes a monoclonal antibody that can bind to lymphocyte-activation gene 3 (LAG-3), which is expected to inhibit its activity. This innovation holds promise for the development of immunotherapeutic agents for various disorders associated with LAG-3. The second patent relates to an antibody against delta-like 1 homolog (DLK1) and encompasses a range of applications, including a pharmaceutical composition for treating cancer and a method for producing the antibody or its fragments.
Career Highlights
Sunha Yoon is currently associated with Y-Biologics Inc., where he continues to advance his research in immunotherapy. His work has positioned him as a key figure in the development of novel therapeutic strategies aimed at enhancing immune responses against diseases.
Collaborations
Yoon collaborates with notable colleagues such as Ji-Young Shin and Sang Pil Lee, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Sunha Yoon's contributions to immunotherapy through his patents highlight his role as an influential inventor in the field. His work not only advances scientific knowledge but also holds the potential for significant therapeutic applications.